BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu., European Association for the Study of the Liver. EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis. J Hepatol 2022:S0168-8278(21)02033-X. [PMID: 35300861 DOI: 10.1016/j.jhep.2021.09.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Biswas S, Vaishnav M, Pathak P, Gunjan D, Mahapatra SJ, Kedia S, Rout G, Thakur B, Nayak B, Kumar R, Shalimar. Effect of thrombocytopenia and platelet transfusion on outcomes of acute variceal bleeding in patients with chronic liver disease. World J Hepatol 2022; 14(7): 1421-1437 [DOI: 10.4254/wjh.v14.i7.1421] [Reference Citation Analysis]
2 Tosetti G, Primignani M. Author's reply: "Staging the pre-procedural prophylaxis in decompensated cirrhosis". Digestive and Liver Disease 2022. [DOI: 10.1016/j.dld.2022.05.003] [Reference Citation Analysis]
3 Reynard ME, Dufour JF. Elective percutaneous liver biopsy and use of aspirin. United European Gastroenterol J 2022. [PMID: 35652196 DOI: 10.1002/ueg2.12254] [Reference Citation Analysis]
4 Zanetto A, Campello E, Spiezia L, Burra P, Simioni P, Senzolo M. Staging the pre-procedural prophylaxis in decompensated cirrhosis. Digestive and Liver Disease 2022. [DOI: 10.1016/j.dld.2022.04.023] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Subhani M, Sheth A, Ahmed J, Wijayasiri P, Gardezi SA, Enki D, Morling JR, Aithal GP, Ryder SD, Aravinthan AD. Incidence and prevalence of venous thromboembolism in chronic liver disease: A systematic review and meta-analysis. Thromb Res 2022;215:19-29. [PMID: 35594737 DOI: 10.1016/j.thromres.2022.05.004] [Reference Citation Analysis]
6 Giannini EG, Lisman T. The international normalized ratio - Great for prediction of bleeding in patients taking vitamin K antagonists, useless for prediction of bleeding in patients with chronic liver disease. J Thromb Haemost 2022;20:1565-7. [PMID: 35754010 DOI: 10.1111/jth.15756] [Reference Citation Analysis]
7 van den Boom BP, Lisman T. Pathophysiology and management of bleeding and thrombosis in patients with liver disease. Int J Lab Hematol 2022. [PMID: 35446468 DOI: 10.1111/ijlh.13856] [Reference Citation Analysis]
8 Zanetto A, Campello E, Bulato C, Gavasso S, Saggiorato G, Shalaby S, Burra P, Angeli P, Senzolo M, Simioni P. Global hemostatic profiling in patients with decompensated cirrhosis and bacterial infections. JHEP Reports 2022. [DOI: 10.1016/j.jhepr.2022.100493] [Reference Citation Analysis]